A novel AMH missense mutation in a patient with persistent Mullerian duct syndrome. (25/35)

 (+info)

Macrosomia and ambiguous genitalia: a long overdue answer to the citizens of Frusino. (26/35)

In the literature of the Roman Era, a case of macrosomia and genital ambiguity in a newborn is described. Textual evidence concerning this case of androgynism and its symbolism is provided in the present study. Medical interpretation of such cases covers the entire spectrum of differential diagnosis of macrosomia concurrent with genital ambiguity. Female pseudohermaphroditism may be excluded from the differential diagnosis, as the adrenal cortex physiology of the female fetus renders the concurrence of overgrowth and androgen excess unlikely. It will therefore have been a case of 46XY disorder of sexual differentiation due to either fetal overgrowth syndromes (Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes) or to mutations of the WT1 gene. Mutations of the WT1 gene are considered as the most probable diagnosis, resulting in genital ambiguity and macrosomia due to additional altered insulin-like growth factor I (IGF-I) and IGF-II action.  (+info)

A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development. (27/35)

 (+info)

Long-term clinical data and molecular defects in the STAR gene in five Greek patients. (28/35)

 (+info)

Analysis of anti-Mullerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Mullerian duct syndrome. (29/35)

 (+info)

Diagnosis of 5alpha-reductase 2 deficiency: is measurement of dihydrotestosterone essential? (30/35)

 (+info)

Identification of novel mutations in STAR gene in patients with lipoid congenital adrenal hyperplasia: a first report from India. (31/35)

 (+info)

Cryptic genomic rearrangements in three patients with 46,XY disorders of sex development. (32/35)

 (+info)